文献速递肝病

清道夫受体A是抑制药物性肝损伤的主要稳态调节因子

Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury.
PubMed 文献 · Hepatology · 2023-01-13

本文探讨模式识别清道夫受体A(SRA)在药物性肝损伤中的调控作用。利用对乙酰氨基酚(APAP)或氟烷诱导的肝损伤模型,发现SRA缺失使小鼠对药物肝毒性高度易感,表现为死亡率和肝脏病理增加;机制上SRA通过库普弗细胞促进IL-10产生,抑制肝细胞JNK信号通路活化,从而维持肝脏稳态。

要点

  • SRA缺失小鼠对APAP或氟烷诱导的肝损伤更易感,死亡率和肝脏病理增加。
  • SRA的保护作用主要依赖于免疫哨兵库普弗细胞,通过促进IL-10产生实现。
  • IL-10与N-乙酰半胱氨酸联用可增强对APAP诱导肝损伤的保护。

核心结论

  • 识别出由免疫受体SRA调控的肝细胞外源性通路,在药物刺激下维持肝脏稳态。
  • 靶向SRA-IL-10轴可能为优化药物性肝损伤的当前管理提供新机会。

研究设计与样本

  • 使用对乙酰氨基酚(APAP)或氟烷诱导的肝损伤小鼠模型。
  • 采用骨髓重建和脂质体氯膦酸盐清除研究。
  • 在人体中观察APAP摄取后SRA与IL-10表达的相关性。

主要发现

  • SRA缺失小鼠在APAP或氟烷诱导的肝损伤中死亡率和肝脏病理增加。
  • SRA缺失时APAP诱导的肝损伤加重与抗炎及促生存细胞因子IL-10减少及过度肝脏炎症相关。
  • 人体中APAP摄取后也可见SRA与IL-10表达的类似相关性。
  • SRA的保肝活性主要存在于免疫哨兵库普弗细胞中。
  • SRA促进库普弗细胞响应受损肝细胞产生IL-10,减轻肝细胞中Jun N端激酶介导的信号通路活化。

临床怎么用

  • 作者认为靶向SRA-IL-10轴可能为优化药物性肝损伤的当前管理提供新机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Drug-induced liver injury occurs frequently and can be life threatening. Although drug-induced liver injury is mainly caused by the direct drug cytotoxicity, increasing evidence suggests that the interplay between hepatocytes and immune cells can define this pathogenic process. Here, we interrogate the role of the pattern recognition scavenger receptor A (SRA) for regulating hepatic inflammation and drug-induced liver injury. APPROACH AND RESULTS: Using acetaminophen (APAP) or halothane-induced liver injury models, we showed that SRA loss renders mice highly susceptible to drug hepatotoxicity, indicated by the increased mortality and liver pathology. Mechanistic studies revealed that APAP-induced liver injury exaggerated in the absence of SRA was associated with the decreased anti-inflammatory and prosurvival cytokine IL-10 concomitant with excessive hepatic inflammation. The similar correlation between SRA and IL-10 expression was also seen in human following APAP uptake. Bone marrow reconstitution and liposomal clodronate depletion studies established that the hepatoprotective activity of SRA mostly resized in the immune sentinel KCs. Furthermore, SRA-facilitated IL-10 production by KCs in response to injured hepatocytes mitigated activation of the Jun N-terminal kinase-mediated signaling pathway in hepatocytes. In addition, supplemental use of IL-10 with N -acetylcysteine, only approved treatment of APAP overdose, conferred mice improved protection from APAP-induced liver injury. CONCLUSION: We identify a novel hepatocyte-extrinsic pathway governed by the immune receptor SRA that maintains liver homeostasis upon drug insult. Giving that drug (ie, APAP) overdose is the leading cause of acute liver failure, targeting this hepatoprotective SRA-IL-10 axis may provide new opportunities to optimize the current management of drug-induced liver injury.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Guo C, Liu W, Liu Z, et al. Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury. Hepatology. 2023. PMID: 36632993. doi:10.1097/HEP.0000000000000044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。